HILBARI Trademark

Trademark Overview

On Friday, October 3, 2025, a trademark application was filed for HILBARI with the United States Patent and Trademark Office. The USPTO has given the HILBARI trademark a serial number of 99426804. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, October 3, 2025. This trademark is owned by Celldex Therapeutics, Inc.. The HILBARI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of mast-cell mediated disorders; Pharmaceutical preparations for the treatment of urticaria; Pharmaceutical preparations for the treatment of chronic spontaneous urticaria (CSU); Pharmaceutical preparations for the treatment of chronic inducible urticaria (CIndU); Pharmaceutical preparations for the treatment of prurigo nodularis (PN); Pharmaceutical preparations for the treatment of atopic dermatitis (AD); Pharmaceutical preparations for the treatment of cold urticaria (ColdU); Pharmaceutical preparations for the treatment of symptomatic dermographism (SD); Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of inflammatory diseases
hilbari

General Information

Serial Number99426804
Word MarkHILBARI
Filing DateFriday, October 3, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, October 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of mast-cell mediated disorders; Pharmaceutical preparations for the treatment of urticaria; Pharmaceutical preparations for the treatment of chronic spontaneous urticaria (CSU); Pharmaceutical preparations for the treatment of chronic inducible urticaria (CIndU); Pharmaceutical preparations for the treatment of prurigo nodularis (PN); Pharmaceutical preparations for the treatment of atopic dermatitis (AD); Pharmaceutical preparations for the treatment of cold urticaria (ColdU); Pharmaceutical preparations for the treatment of symptomatic dermographism (SD); Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of inflammatory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelldex Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827

Trademark Events

Event DateEvent Description
Friday, October 3, 2025NEW APPLICATION ENTERED
Friday, October 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 3, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

hilbari treatment pharmaceutical preparations urticaria chronic inflammatory diseases antibodies cold dermographism